HemAryo

eptacog alfa (activated) · UGA Biopharma

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HemAryo, covering 2022-09-27 to 2022-09-27. Get the full timeline:

Most recent: EMA Application withdrawn: HemAryo (eptacog alfa (activated)) — UGA Biopharma